Stocks and Investing
Stocks and Investing
Fri, November 6, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Danielle Antalffy Maintained (TNDM) at Hold with Increased Target to $130 on, Nov 6th, 2020
Danielle Antalffy of SVB Leerink, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Increased Target from $120 to $130 on, Nov 6th, 2020.
Danielle has made no other calls on TNDM in the last 4 months.
There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, 0 agree with Danielle's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Danielle
- Lawrence Biegelsen of "Wells Fargo" Initiated at Buy and Held Target at $120 on, Thursday, August 20th, 2020
- Joanne Wuensch of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $120 on, Monday, July 6th, 2020
Contributing Sources